期刊文献+

体外心脏震波治疗老年冠心病患者的疗效和安全性分析 被引量:16

Application of extracorporeal cardiac shock wave therapy in treating coronary heart disease in the elderly
原文传递
导出
摘要 目的探讨体外心脏震波系统(CSWT)治疗老年冠心病患者的有效性和安全性。方法11例顽固性心绞痛的老年冠心病患者。根据心肌核素显像和冠状动脉造影结果确定缺血心肌靶目标,行CSWT治疗。疗程为3个月,共治疗9次。疗效评价分别采用临床症状描述、加拿大心血管学会心绞痛(CCS)分级、6min步行试验、纽约心功能心脏病学会心功能(NYHA)分级、西雅图心绞痛量表(SAQ)、硝酸甘油使用量、左心室舒张末期直径(LVEDD)和左心室射血分数(LVEF)等;心肌核素显像评价治疗前后心肌缺血改善情况;观察患者治疗过程中症状、心电监测、血压和氧饱和度变化、治疗后肌酸激酶(CK)、肌酸激酶同工酶(CK—MB)、肌钙蛋白T、丙氨酸氨基转移酶(ALT)、肌酐、脑钠肽和超敏C反应蛋白(HsCRP)的变化评价萁安全性。结果CCS分级、NYHA分级、6min步行试验和硝酸甘油用量在治疗第4个月和1年与治疗前相比均有改善(P〈0.05)。心绞痛稳定状态和疾病认识程度有明显改善,较治疗前差异均有统计学意义(P〈0.05)。共治疗21个节段,治疗后静息状态心肌缺血的改善率为46.2%(6/13),其中有效率为38.5%(5/13),明显有效率为7.8%(1/13);负荷状态心肌缺血的改善率为57.1%(12/21),其中有效率为47.6%(10/21),明显有效率为9.5%(2/21)。与治疗前比较,CK、CK—MB、肌钙蛋白、ALT肌酐、脑钠肽和HsCRP均无明显改变,心率、收缩压、舒张压和氧饱和度亦无明显变化。结论CSWT是一种安全、有效治疗老年冠心病患者的方法,并能保持疗效至少1年。 Objective To evaluate the efficacy and safety of cardiac shock wave therapy(CSWT) in coronary heart disease in elderly patients. Methods Eleven patients with refractory angina pectoris were enrolled. The ischemic area was determined by the 99mTechnetium-MIBI single-photon emission computed tomography (SPECT) and coronary angiography, and treated with CSWT. The CSWT were performed during treatment of 3 months, with 9 times totally. The clinical evaluations included the clinical symptoms, Canadian Cardiovascular Society (CCS) class scores, New York Heart Association class (NYHA), Seattle angina questionnaire (SAQ), 6 min walking distance and the use of dosage of nitroglycerin, left ventricular end diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF). The amelioration of ischemic myocardial was analyzed by SPECT. The safety of CSWT was evaluated by changes in clinical symptoms, ECG monitoring, blood pressure and oxygen saturation, blood levels of creatine kinase, creatine kinase myocardial band isoenzymes (CK MB), troponin T (TnT), alanine transfer enzyme (ALT), creatinine (CR), brain natriuretic peptide and high sensitive C reactive protein (hs CRP). Results The CCS class scores, NYHA, 6-rain walking distance and the dosage of nitroglycerin were significantly improved at 4 and 12 months after treatment as compared with pretreatment. The steady state of angina pectoris and the frequency score in SAQ were significantly improved. The 21 cardio-vessel segments were treated, and the improvement rate of resting myocardial perfusion was 46.2%(6/13), the effective rate was 38.5%(5/13), and the obvious effective rate was 7.8% (1/13) after treatment. The improvement rate of loaded myocardial perfusion was 57.1%(12/21), the effective rate was 47.6%(10/21), and the obvious effective rate after treatment was 9.5 % (2/21). There were no significant changes in levels of CK, CK-MB, TNT, ALT, Cr, BNP and hs CRP, heart rate, systolic blood pressure, diastolic blood pressure and oxygen saturation after treatment as compared with pretreatment. Conclusions The CSWT is a safe and effective treatment for coronary heart disease in the elderly, and the curative effect could maintain at least one year.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2015年第7期736-740,共5页 Chinese Journal of Geriatrics
基金 首都市民健康项目培育
关键词 冠心病 放射性核素显像 体外心脏震波 Coronary disease Radionuclide imaging Extracorporeal cardiac shock wave
作者简介 通信作者:何青,Email:heqingli2001@126.com
  • 相关文献

参考文献12

  • 1Flather M, Rhee JW, Boothroyd DB, et al. The effect of age on outcomes of coronary artery bypass surgery compared w~th balloon angioplasty or bare metal stent implantation among patients with multivessel coronary disease: a collaborative analysis of individual patient data {rom 10 randomized trials [J]. J Am Coll Cardiol, 2012,60:2150 2157.
  • 2Nishida T, Shimokawa H, Oi K, et al. Extraeorporeal cardiac shock wave therapy markedly ameliorates ischemiainduced myocardial dysfunction in pigs in vivo[J].Circulation, 2004, 110:3055-3061.
  • 3Aicher A, Heeschen C, Sasaki K, et al. Low energy shock wave for enhancing recruitment o{ endothelial progenitor Cells [J].Circulation, 2006, 114: 2823-2830.
  • 4Mariotto g, de Prati AC, Cavalieri E, et al. Extracorporeal shock wave therapy in inflammatory diseases= molecular mechanism that triggers anti inflammatory action [J]. Curt Med Chem,2009, 16~ 2366-2372.
  • 5Yu W, Shen T, Liu B, et al. Cardiac shock wave therapy attenuates H9C2 myoblast apoptosis by activating the AKT signal pathway[J]. Cell Physiol Biochem, 2014,33 : 1293 303.
  • 6Fukumoto Y,Ito A, Uwatoku T, et ah Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery Disease[J].Coron Artery Dis, 2006, 17:63-70.
  • 7王钰,郭涛,蔡红雁,马铁昆,陶四明,陈明清,顾云,潘家华,肖践明,赵玲,杨西云,羊超.体外心脏震波治疗冠心病的应用研究[J].中华心血管病杂志,2010,38(8):711-715. 被引量:20
  • 8Kikuchi Y, Ito K, ho Y, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina peetoris [J]..Cire J, 2010, 74: 589-591.
  • 9Vasyuk YA, I-Iadzeqova AB, Shkolnik EL, ctal. Initial linical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure[J]. Congest Heart Fail, 2010,16:226 223.
  • 10彭云珠,郭涛,杨萍,杨洪文,周平,王钰,骆志玲,顾云,潘家华.体外心脏震波治疗缺血性心力衰竭的初步观察[J].中华心血管病杂志,2012,40(2):141-146. 被引量:16

二级参考文献15

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2117
  • 2Buszman P.Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy.Am J Cardiol,2007,99:36-41.
  • 3Hunt SA,Abraham WT,Chin MH,et al.2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.J Am Coll Cardiol,2009,53:e1-e90.
  • 4Pennel D J,Ray SD,Dabies G,et al.The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS)study: methodology of a randomised, placebo controlled,multicentre study of carvedilol in hibernation and heart failure.Int J Cardiol,2000,72:265-274.
  • 5Fu M,Sun CK, Lin YC,et al. Extracorporeal wave therapy reverses ischemia-related left ventricular dysfunction and remodeling:molecular-cellular and functional assessment. Plos One,2011,6:e24342.
  • 6Nishida T,Shimokawa H,Oi K,et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia induced myocardial dysfunction in pigs in vivo.Circulation,2004,110:3055-3061.
  • 7Fukumoto Y,Ito A,Uwatoku T,et al.Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease.Coron Artery Dis,2006,17:63-70.
  • 8Kikuchi Y,Ito K,Ito Y,et al. Double-blind and placebocontrolled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J,2010,74:589-591.
  • 9Yang H, Pu M, Rodriguez D,et al. Ischemic and viable myocardiumin patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction:a clinical study using positron emission tomography, echocardiography, and electrocardiography.J Am Coll Cardiol,2004,43:592-598.
  • 10Camici PG,Prasad SK,Rimoldi OE.Stunning,hibernation,and assessment of myocardial viability.Circulation,2008,117:103-114.

共引文献32

同被引文献119

引证文献16

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部